Research Article

Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages

Volume: 13 Number: 1 May 11, 2023
EN

Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages

Abstract

Objective: Endometriosis is a gynecological disease associated with chronic pelvic inflammation, pain, and infertility. Galectin-3 (Gal-3) is a protein that can bind to β-galactosides, which plays an important role in different biological processes according to the stages of the disease in patients with endometriosis. This study aimed to elucidate the importance of Gal-3 in endometriosis, to reveal its potential power as a non-invasive diagnostic biomarker in disease etiopathogenesis. Materials and Methods: The serum concentration of Gal-3 and cancer antigen 125 (CA-125) from whole blood were measured using enzyme-linked immuno sorbent assay (ELISA) and an auto-analyzer, respectively. Gal-3 expression was determined by quantitative real-time polymerase chain reaction (qRT-PCR) from peripheral blood. Results: We found significant differences for Gal-3 expression levels between the endometriosis and control groups (p <0.05). Gal-3 levels in the serum of women with endometriosis are also remarkably increased compared with the control group. Conclusion: Galectin-3 can play critical functions in the development and progression of endometriosis, so, further studies are needed in this area

Keywords

Supporting Institution

sivas cumhuriyet univeristesi araştırma başkanlığı CUBAP

Project Number

Ecz-075

References

  1. 1. Bulun SE. Mechanisms of disease endometriosis. N Engl J Med 2009; 360: 268-79. [CrossRef] google scholar
  2. 2. Pabalan N, Jarjanazi H, Christofolini DM, Barbosa CP, Bianco B. Association of the intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms with endometriosis: A systematic review and metaanalysis. Arch Gynecol Obstet 2015; 292: 843-51. [CrossRef] google scholar
  3. 3. Meggyes M, Szereday L, Bohonyi N, Koppan M, Szegedi S, Marics-Kutas A et al. Different expression pattern of TIM-3 and Galectin-9 molecules by peripheral and peritoneal lymphocytes in women with and without endometriosis. Int J Mol Sci 2020; 21(7): 2343. [CrossRef] google scholar
  4. 4. Aghajanpour L, Mashayekhi F, Rajaei F. Intercellular adhesion molecule-1 (ICAM-1) gene polymorphism and endometriosis in northern Iran. Arch Gynecol Obstet 2011; 283:1035-9. [CrossRef] google scholar
  5. 5. Caserta D, Di Benedetto L, Bordi G, D’Ambrosio A, Moscarini M. Levels of Galectin-3 and stimulation expressed gene 2 in the peritoneal fluid of women with endometriosis: A pilot study. Gynecol Endocrinol 2014; 30(12): 877-80. [CrossRef] google scholar
  6. 6. Sharpe Timms KL. Endometrial anomalies in women with endometriosis. Ann NY Acad Sci 2001; 943: 131-47. [CrossRef] google scholar
  7. 7. Bastón JI, Barañao RI, Ricci AG, Bilotas MA, Olivares CN, Singla JJ. Targeting galectin-1-induced angiogenesis mitigates the severity of endometriosis. J Pathol 2014; 234(3): 329-37. [CrossRef] google scholar
  8. 8. Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: An update for clinicians. Hum Reprod Update 2006; 12: 179-89. [CrossRef] google scholar

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

May 11, 2023

Submission Date

August 17, 2022

Acceptance Date

March 8, 2023

Published in Issue

Year 2023 Volume: 13 Number: 1

APA
Kızılgedik, D. F., Caner, A., Yıldız, Ç., Okşaşoğlu, B., Mısır, S., Yaylım, İ., Demokan, S., & Hepokur, C. (2023). Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages. Experimed, 13(1), 15-20. https://doi.org/10.26650/experimed.1148905
AMA
1.Kızılgedik DF, Caner A, Yıldız Ç, et al. Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages. Experimed. 2023;13(1):15-20. doi:10.26650/experimed.1148905
Chicago
Kızılgedik, D. Fulya, Armagan Caner, Çağlar Yıldız, et al. 2023. “Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages”. Experimed 13 (1): 15-20. https://doi.org/10.26650/experimed.1148905.
EndNote
Kızılgedik DF, Caner A, Yıldız Ç, Okşaşoğlu B, Mısır S, Yaylım İ, Demokan S, Hepokur C (May 1, 2023) Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages. Experimed 13 1 15–20.
IEEE
[1]D. F. Kızılgedik et al., “Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages”, Experimed, vol. 13, no. 1, pp. 15–20, May 2023, doi: 10.26650/experimed.1148905.
ISNAD
Kızılgedik, D. Fulya - Caner, Armagan - Yıldız, Çağlar - Okşaşoğlu, Buğra - Mısır, Sema - Yaylım, İlhan - Demokan, Semra - Hepokur, Ceylan. “Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages”. Experimed 13/1 (May 1, 2023): 15-20. https://doi.org/10.26650/experimed.1148905.
JAMA
1.Kızılgedik DF, Caner A, Yıldız Ç, Okşaşoğlu B, Mısır S, Yaylım İ, Demokan S, Hepokur C. Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages. Experimed. 2023;13:15–20.
MLA
Kızılgedik, D. Fulya, et al. “Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages”. Experimed, vol. 13, no. 1, May 2023, pp. 15-20, doi:10.26650/experimed.1148905.
Vancouver
1.D. Fulya Kızılgedik, Armagan Caner, Çağlar Yıldız, Buğra Okşaşoğlu, Sema Mısır, İlhan Yaylım, Semra Demokan, Ceylan Hepokur. Investigation of Galectin-3 Levels of Endometriosis Patients According to Stages. Experimed. 2023 May 1;13(1):15-20. doi:10.26650/experimed.1148905